Raziye Piranlioglu, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunity | 1 | 2019 | 957 | 0.470 |
Why?
|
| Tail | 1 | 2019 | 97 | 0.180 |
Why?
|
| Tumor Escape | 1 | 2021 | 328 | 0.170 |
Why?
|
| Lymphocyte Subsets | 1 | 2019 | 325 | 0.170 |
Why?
|
| Multipotent Stem Cells | 1 | 2019 | 201 | 0.170 |
Why?
|
| Mammary Glands, Animal | 1 | 2019 | 277 | 0.160 |
Why?
|
| Genetic Pleiotropy | 1 | 2018 | 177 | 0.160 |
Why?
|
| Exosomes | 1 | 2021 | 400 | 0.150 |
Why?
|
| Neoplasms | 3 | 2021 | 20172 | 0.150 |
Why?
|
| Granulocytes | 1 | 2017 | 562 | 0.140 |
Why?
|
| Veins | 1 | 2019 | 762 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 3693 | 0.120 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 2987 | 0.110 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 16959 | 0.110 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 5112 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2021 | 4254 | 0.090 |
Why?
|
| Monocytes | 1 | 2017 | 2660 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2019 | 3690 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4466 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 18375 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2021 | 3344 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2019 | 10507 | 0.070 |
Why?
|
| Stem Cells | 1 | 2019 | 3593 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2019 | 10803 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3773 | 0.070 |
Why?
|
| Models, Biological | 1 | 2019 | 9907 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8638 | 0.050 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 113 | 0.050 |
Why?
|
| Mice | 4 | 2021 | 80876 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9556 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11253 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 8776 | 0.050 |
Why?
|
| Purine Nucleosides | 1 | 2018 | 30 | 0.050 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2018 | 44 | 0.040 |
Why?
|
| Animals | 6 | 2021 | 170486 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2021 | 787 | 0.040 |
Why?
|
| Macrophages | 2 | 2021 | 5784 | 0.040 |
Why?
|
| RNA, Neoplasm | 1 | 2018 | 780 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 895 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2017 | 542 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2021 | 3859 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 1918 | 0.030 |
Why?
|
| Cell Communication | 1 | 2021 | 1653 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 707 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 2835 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 19800 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1392 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 3878 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 7994 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6684 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2021 | 4057 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 15274 | 0.020 |
Why?
|
| Humans | 5 | 2021 | 708843 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 10085 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11718 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2017 | 20170 | 0.010 |
Why?
|
| Female | 4 | 2021 | 375205 | 0.010 |
Why?
|
| Inflammation | 1 | 2018 | 10019 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 22989 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2018 | 23950 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 12183 | 0.010 |
Why?
|
| Male | 1 | 2021 | 349524 | 0.000 |
Why?
|